{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/30/3303889/0/en/Mineralys-Therapeutics-Presents-New-Data-from-the-Phase-3-Launch-HTN-Trial-of-Lorundrostat-in-Participants-with-Hypertension-and-Chronic-Kidney-Disease-at-European-Meeting-on-Hyper.html", "message": "News view counter 769120 successfully enlarged"}